QUALITY OF LIFE INDICATORS FOR THE PATIENTS WHO SUFFERED FROM COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY SARS-CoV-2

Introduction. Respiratory pathology, both acute and chronic, remains one of the key problems of modern medicine in Ukraine and in the world in general, which is explained by its significant prevalence, negative impact on patients' work capacity, their quality of life, as well as the economic burden on society. The aim of the study – to analyze the subjective state of health using the SF-36 questionnaire for patients who undergone community-acquired pneumonia caused by SARS-CoV-2 in 1 year after inpatient treatment. Research Methods. A retrospective study of the medical records of 208 patients who had been hospitalized for non-hospital pneumonia with a negative smear test for the SARS-CoV-2 virus was conducted. The severity of pneumonia was calculated according to the PORT scale. The comparison group consisted of patients with SARS-CoV-2 nucleic acid identification and the absence. A telephone survey to assess the quality of life of the participants of the first stage of our study 1 year after discharge from the hospital were performed. The general investigator SF-36 was used to assess quality of life. Statistical analysis of data was carried out using the "STATISTICA 7.0" software. Results and Discussion. Physical functioning according to SF-36 was the lowest in the observation group IV and probably differed in relation to the data of the observation group II and the comparison group. Analyzing the general state of health, the values were found to be probably lower for patients who suffered from community-acquired pneumonia of 3rd and 4th categories of severity compared to the data of the observation group II and the comparison group. Conclusion. Thus, it was established low quality of life in patients after pneumonia caused by COVID-19. Practical value of the work consists in improving diagnostics and therapy, as well as improving the rehabilitation of patients who suffered from community-acquired pneumonia caused by SARS-CoV-2.